Adherium Ltd has released a press release.
Appendix 4C - quarterly for period ended 30 Sept 2016
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Adherium
- Key Technology Patent Granted in US
- Adherium and AstraZeneca Australia Commercial Pilot Program
- Adherium Executes Placement to Fidelity International
- Adherium Smartinhaler in AstraZeneca COPD Study
- Clearance to Market in Canada for Flagship Products
Later from Adherium
- Adherium Smartinhaler dramatically improves outcomes
- NICE reports on Adherium Smartinhaler for asthma management
- Appendix 4C - quarterly December 2016
- Adherium Appoints New CEO to Drive Global Growth
- Commitments Test Entity - Fourth Quarter Report
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium